Standout Papers

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice 1994 2026 2004 2015 3.5k
  1. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice (1994)
    Tsvee Lapidot, Christian Sirard et al. Nature
  2. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia (2001)
    Scott A. Armstrong, Jane Staunton et al. Nature Genetics
  3. Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (2012)
    Hagop M. Kantarjian, Xavier Thomas et al. Journal of Clinical Oncology
  4. Stem cell gene expression programs influence clinical outcome in human leukemia (2011)
    Kolja Eppert, Katsuto Takenaka et al. Nature Medicine
  5. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations (2010)
    Stefan Größ, Rob A. Cairns et al. The Journal of Experimental Medicine
  6. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia (2012)
    Tino Schenk, Weihsu Claire Chen et al. Nature Medicine
  7. A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects (2018)
    Yuki Kagoya, Shinya Tanaka et al. Nature Medicine
  8. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia (2022)
    Andy G.X. Zeng, Liqing Jin et al. Nature Medicine

Immediate Impact

13 by Nobel laureates 58 from Science/Nature 179 standout
Sub-graph 1 of 14

Citing Papers

CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel

Works of Mark D. Minden being referenced

A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
2018 Standout

Author Peers

Author Last Decade Papers Cites
Mark D. Minden 8108 11796 6901 505 23.1k
Giuseppe Basso 6643 9991 4299 532 23.7k
Edo Vellenga 8523 7534 5215 481 18.4k
James D. Griffin 12277 12646 7357 352 29.3k
Guido Marcucci 9715 14115 3189 484 22.4k
Marina Konopleva 15161 15511 7723 900 29.7k
Wolfgang E. Berdel 7249 11176 5027 495 20.9k
Carsten Müller‐Tidow 5283 11619 4347 503 18.2k
Andrew L. Kung 4058 16386 6498 282 23.8k
Gerhard Ehninger 13344 6007 6426 677 24.5k
Axel Benner 6010 9580 6253 396 23.6k

All Works

Loading papers...

Rankless by CCL
2026